Fluorescence Guided Surgery Systems Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028
Fluorescence guided surgery (FGS) systems are used to identify and visualize tissues during surgical procedures by using fluorescent dyes or probes. These systems can improve surgical accuracy and reduce the risk of complications by allowing surgeons to see the location of diseased or abnormal tissue more clearly. Fluorescence guided surgery systems have been used for a wide range of surgical applications, including oncology, neurosurgery, urology, and cardiovascular surgery.
The
Fluorescence
Guided Surgery Systems Market has
been growing rapidly in recent years due to advances in imaging technology, an
aging population, and increasing demand for minimally invasive surgical
procedures. According to a report by Grand View Research, the global
fluorescence guided surgery systems market was valued at $781.5 million in 2020
and is expected to grow at a compound annual growth rate (CAGR) of 8.8% from
2021 to 2028.
The
use of Fluorescence Guided Surgery Systems
Market has
several advantages over traditional surgical techniques. First, these systems
can improve surgical accuracy by allowing surgeons to see the precise location
of diseased or abnormal tissue. This can help to reduce the risk of
complications, such as damage to surrounding tissues or organs. Second,
fluorescence guided surgery systems can reduce the need for invasive procedures
by allowing surgeons to target specific areas of tissue with greater precision.
This can result in less tissue damage and faster recovery times for patients.
The
Fluorescence Guided Surgery Systems
Market is
segmented by product type, application, end-user, and region. Product types
include imaging systems, probes, and surgical instruments. Imaging systems are
the largest segment of the market, accounting for more than 60% of total
revenue. Applications for fluorescence guided surgery systems include oncology,
neurosurgery, urology, cardiovascular surgery, and others. Oncology is the
largest application segment, accounting for nearly 50% of total revenue.
End-users of fluorescence
guided surgery systems include hospitals, clinics, and ambulatory surgical
centers. Hospitals are the largest end-user segment, accounting for more than
50% of total revenue. This is due to the high cost of fluorescence guided
surgery systems, which makes them more accessible to larger healthcare
providers.
Geographically, the
fluorescence guided surgery systems market is segmented into North America,
Europe, Asia Pacific, Latin America, and Middle East & Africa. North
America is the largest market, accounting for more than 40% of total revenue.
This is due to the high adoption rate of new technologies in the region, as
well as the presence of several major healthcare providers. Europe is the
second largest market, followed by Asia Pacific.
The major players in the
fluorescence guided surgery systems market include companies such as Carl Zeiss
Meditec AG, Olympus Corporation, Novadaq Technologies Inc., and Leica
Microsystems GmbH. These companies are focused on developing new products and
expanding their presence in emerging markets to capitalize on the growing
demand for fluorescence guided surgery systems.
Comments
Post a Comment